Results 271 to 280 of about 645,099 (360)
Global strategies and actions to eliminate hepatitis B virus infection. [PDF]
Lin CL, Kao JH.
europepmc +1 more source
A hepatitis B virus RNA-sensing and RNA-editing-dependent reporter system. [PDF]
Sun L, Snedeker A, Tang L.
europepmc +1 more source
Antiviral and immune modulatory activities of STING agonists in a mouse model of persistent hepatitis B virus infection. [PDF]
Wang Y +9 more
europepmc +1 more source
Potential Applications of RNase P Ribozyme Against Hepatitis B Virus. [PDF]
Sorrell T, Liu Y, Liu F.
europepmc +1 more source
What's New? Hepatocellular carcinoma arises from a combination of environmental and genetic factors, with the latter playing a potentially more significant role in nonviral hepatocellular carcinoma. Here, the authors characterized the genetic correlations and heritability between nonviral hepatocellular carcinoma and 901 epidemiologic, behavioral, and ...
Younghun Han +37 more
wiley +1 more source
Hepatitis B Virus Assembly: Cryo-Electron Microscopy Reveals Structure of the Surface Antigen. [PDF]
Li G, Cui J, Nie J.
europepmc +1 more source
What's New? Disruption of the gut–liver axis has been suggested to play an important role in liver carcinogenesis. However, limited prospective research has explored associations between potentially harmful gut‐derived bacterial products and liver cancer risk.
Cody Z. Watling +36 more
wiley +1 more source
Global prevalence of occult hepatitis B virus infection in HBcAb-positive individuals: a systematic review and meta-analysis. [PDF]
Yang Y, Xing H, Wu G, Zhao Y.
europepmc +1 more source
Controlled trial of cervical cancer screening frequency among human‐papillomavirus‐vaccinated women
What's New? Since the introduction of the human papillomavirus (HPV) vaccine in 2006, vaccine‐type infections have declined markedly. As nonvaccine HPV types generally carry lower oncogenic potential, this shift warrants reevaluation of cervical screening regimens.
Mònica Ortega Llobet +10 more
wiley +1 more source

